Regulation of Androgen Receptor Activity by Transient Interactions of Its Transactivation Domain with General Transcription Regulators.

[1]  B. Al-Lazikani,et al.  Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer , 2017, eLife.

[2]  Paul Workman,et al.  Drug discovery in advanced prostate cancer: translating biology into therapy , 2016, Nature Reviews Drug Discovery.

[3]  X. Salvatella,et al.  EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor. , 2016, ACS chemical biology.

[4]  Monika Fuxreiter,et al.  The Structure and Dynamics of Higher-Order Assemblies: Amyloids, Signalosomes, and Granules , 2016, Cell.

[5]  J. Forman-Kay,et al.  Modulation of Intrinsically Disordered Protein Function by Post-translational Modifications , 2016, The Journal of Biological Chemistry.

[6]  Lawrence D. True,et al.  Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.

[7]  Patrick Cramer,et al.  Structural basis of transcription initiation by RNA polymerase II , 2015, Nature Reviews Molecular Cell Biology.

[8]  L. Kay,et al.  Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch , 2014, Nature.

[9]  H. Dyson,et al.  Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.

[10]  Chunhong Yan,et al.  Determinants of Gli2 co‐activation of wildtype and naturally truncated androgen receptors , 2014, The Prostate.

[11]  Daniel Gioeli,et al.  Post-translational modification of the androgen receptor , 2012, Molecular and Cellular Endocrinology.

[12]  R. Vernon,et al.  The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex. , 2011, Molecular cell.

[13]  V. Hilser,et al.  Structural Dynamics, Intrinsic Disorder, and Allostery in Nuclear Receptors as Transcription Factors* , 2011, The Journal of Biological Chemistry.

[14]  M. Sadar.  Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity. , 2011, Cancer research.

[15]  John T. Lis,et al.  Defining mechanisms that regulate RNA polymerase II transcription in vivo , 2009, Nature.

[16]  J. Omichinski,et al.  NMR structure of a complex formed by the carboxyl-terminal domain of human RAP74 and a phosphorylated peptide from the central domain of the FCP1 phosphatase. , 2009, Biochemistry.

[17]  A. Wlodawer,et al.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. , 2009, Structure.

[18]  H. Dyson,et al.  Linking folding and binding. , 2009, Current opinion in structural biology.

[19]  P. Tompa,et al.  Malleable machines take shape in eukaryotic transcriptional regulation. , 2008, Nature chemical biology.

[20]  Patrick Aloy,et al.  Contextual Specificity in Peptide-Mediated Protein Interactions , 2008, PloS one.

[21]  I. McEwan,et al.  Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a. , 2008, Biochemistry.

[22]  I. McEwan,et al.  Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. , 2008, Biochemistry.

[23]  D. Tindall,et al.  Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells. , 2007, Cancer research.

[24]  U. Landegren,et al.  Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.

[25]  I. McEwan,et al.  The role of the general transcription factor IIF in androgen receptor-dependent transcription. , 2006, Molecular endocrinology.

[26]  Toshiaki Hara,et al.  Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. , 2006, Molecular cell.

[27]  F. Speleman,et al.  A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution. , 2005, Molecular biology and evolution.

[28]  I. McEwan,et al.  Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding. , 2005, Journal of molecular endocrinology.

[29]  M. J. Chalmers,et al.  Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation. , 2005, Biochemistry.

[30]  H. Dyson,et al.  Unfolded proteins and protein folding studied by NMR. , 2004, Chemical reviews.

[31]  Raj Kumar,et al.  Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. , 2004, Biochemistry.

[32]  D. Wishart,et al.  Rapid and accurate calculation of protein 1H, 13C and 15N chemical shifts , 2003, Journal of biomolecular NMR.

[33]  J. Greenblatt,et al.  NMR structure of a complex containing the TFIIF subunit RAP74 and the RNA polymerase II carboxyl-terminal domain phosphatase FCP1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Greenblatt,et al.  Solution structure of the carboxyl-terminal domain of RAP74 and NMR characterization of the FCP1-binding sites of RAP74 and human TFIIB. , 2003, Biochemistry.

[35]  S. Burley,et al.  Molecular mechanism of recruitment of TFIIF- associating RNA polymerase C-terminal domain phosphatase (FCP1) by transcription factor IIF , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. McEwan,et al.  The Androgen Receptor Interacts with Multiple Regions of the Large Subunit of General Transcription Factor TFIIF* , 2002, The Journal of Biological Chemistry.

[37]  J. Darnell.  Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[38]  S K Burley,et al.  Crystal structure of the C-terminal domain of the RAP74 subunit of human transcription factor IIF , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Melcher,et al.  The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins. , 2000, Journal of molecular biology.

[40]  J. A. Kemppainen,et al.  FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor* , 2000, The Journal of Biological Chemistry.

[41]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[42]  N. Weigel,et al.  Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. , 1999, Human molecular genetics.

[43]  J. Greenblatt,et al.  An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Levine,et al.  Induced α Helix in the VP16 Activation Domain upon Binding to a Human TAF , 1997 .

[45]  J. Gustafsson,et al.  Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Jenster,et al.  Identification of Two Transcription Activation Units in the N-terminal Domain of the Human Androgen Receptor (*) , 1995, The Journal of Biological Chemistry.

[47]  Luis Serrano,et al.  Elucidating the folding problem of helical peptides using empirical parameters , 1994, Nature Structural Biology.

[48]  F. Claessens,et al.  Interplay between two hormone-independent activation domains in the androgen receptor. , 2006, Cancer research.